7 CEVENFACTA

Serial Number 79352435
Registration 7265392
700

Registration Progress

Application Filed
Sep 14, 2022
Under Examination
Approved for Publication
Oct 24, 2023
Published for Opposition
Oct 24, 2023
Registered
Jan 9, 2024

Trademark Image

7 CEVENFACTA

Basic Information

Serial Number
79352435
Registration Number
7265392
Filing Date
September 14, 2022
Registration Date
January 9, 2024
Published for Opposition
October 24, 2023
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 9, 2024
Registration
Registered
Classes
005

Rights Holder

Laboratoire Français du Fractionnement et des Biotechnologies

99
Address
3, avenue des Tropiques
F-91940 Les Ulis
FR

Ownership History

Laboratoire Français du Fractionnement et des Biotechnologies

Original Applicant
99
FR

Laboratoire Français du Fractionnement et des Biotechnologies

Owner at Publication
99
FR

Laboratoire Français du Fractionnement et des Biotechnologies

Original Registrant
99
FR

Legal Representation

Attorney
Luna M. Samman

USPTO Deadlines

Next Deadline
1640 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-01-09)
Due Date
January 09, 2030
Grace Period Ends
July 09, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

26 events
Date Code Type Description
May 21, 2024 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB
May 4, 2024 NREP P NEW REPRESENTATIVE AT IB RECEIVED
Apr 11, 2024 XXSS O GENERIC MADRID TRANSACTION SENT TO IB
Apr 11, 2024 XXCR P GENERIC MADRID TRANSACTION CREATED
Apr 9, 2024 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 9, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER
Jan 9, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 24, 2023 GPNX P NOTIFICATION PROCESSED BY IB
Oct 24, 2023 PUBO A PUBLISHED FOR OPPOSITION
Oct 24, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 4, 2023 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 4, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 4, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 14, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 14, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 13, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 13, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 1, 2023 RFNP P REFUSAL PROCESSED BY IB
Jul 12, 2023 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 11, 2023 RFRR P REFUSAL PROCESSED BY MPU
Jun 7, 2023 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 6, 2023 CNRT R NON-FINAL ACTION WRITTEN
May 31, 2023 DOCK D ASSIGNED TO EXAMINER
Oct 18, 2022 MAFR O APPLICATION FILING RECEIPT MAILED
Oct 14, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 13, 2022 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Detailed Classifications

Class 005
Pharmaceutical products used for the prevention, treatment and control of bleeding episodes; medicine used for the prevention, treatment and control of bleeding episodes; injectable pharmaceutical preparations used for the prevention, treatment and control of bleeding episodes; medical preparations, namely therapeutic proteins for the treatment of coagulation disorders

Additional Information

Design Mark
The mark consists of an incomplete triangle with curved corners forming a stylized number "7" within its interior appearing next to the stylized wording "CEVENFACTA".

Classification

International Classes
005

USPTO Documents

Loading USPTO documents...